Cargando...
The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is characterized by an enlarged prostate, lower urinary tract symptoms (LUTS), and a decreased urinary flow rate. Common in older men, BPH is a progressive disease that can eventually lead to complications including acute urinary retention (AUR) and the need for BP...
Gardado en:
| Publicado en: | Asian J Urol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Second Military Medical University
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5780290/ https://ncbi.nlm.nih.gov/pubmed/29379733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajur.2017.11.005 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|